- Coordinator
- I3s - Instituto De Investigacao E Inovacao Em Saude Da Universidade Do Porto, Portugal
- Runs
- 1 January 2027 to 31 December 2030
- Status
- Running
- EU funding
- €4.5m
- Total cost
- —
- Partners
- 27 organisations in 11 countries
- Type
- Marie Skłodowska-Curie Action
- Grant agreement
- 101311468
What the project is doing
In the project's own words, from its summary on CORDIS.
In 2021, an estimated 3.4 billion people—about 43% of the world’s population—were living with a neurological condition, underscoring the need for new strategies to understand and treat brain disorders. Decades of predominantly neuron-centric research have not delivered the breakthroughs required to reduce their growing global burden. AstroCirc proposes a shift toward a more complete view of brain circuitry by integrating the roles of astrocytes—the most abundant non-neuronal cells, essential for brain homeostasis and circuit dynamics.
By leveraging astrocyte function, AstroCirc aims to uncover novel disease mechanisms and develop astrocyte-based, disease-modifying therapeutic strategies, expanding the options available to tackle neurological diseases. AstroCirc will train 15 doctoral candidates (DCs) in astrocyte–neuron interactions and neural circuitry, building on the project’s cross-disciplinary and intersectoral framework. DCs will be mentored by leading experts in glial biology and will access advanced methodologies and unique model systems across the consortium.
Their research will span multiple levels of brain organization: from synaptic function as the basic unit of circuits (WP1), to circuit integration within brain networks (WP2), and finally to the development of astrocyte-informed interventions for a broad variety of neurological, neuropsychiatric, and neurodegenerative disorders (WP3). AstroCirc’s impact will be reflected in DCs equipped with strong technical and transferable skills, positioning them for successful careers beyond the project.
Ultimately, AstroCirc will foster a new generation of researchers who drive and advocate for glia-centered approaches within European research and innovation.
Who is involved
| Organisation | City | Country | Role |
|---|---|---|---|
| I3s - Instituto De Investigacao E Inovacao Em Saude Da Universidade Do Porto | Porto | Portugal | Coordinator |
| Technische Universitaet Graz | Graz | Austria | Participant |
| Universitat Wien | Wien | Austria | Participant |
| Gliapharm SA | Geneva | Switzerland | Associatedpartner |
| Biotechnologicky Ustav Av Cr Vvi | Vestec | Czechia | Participant |
| Univerzita Karlova | Praha 1 | Czechia | Associatedpartner |
| Hogan Lovells International LLP | Frankfurt am Main | Germany | Associatedpartner |
| Klinikum Der Universitaet Regensburg | Regensburg | Germany | Participant |
| PHIO scientific GmbH | München | Germany | Associatedpartner |
| Synaptic Systems | Göttingen | Germany | Associatedpartner |
| Universitaet Regensburg | Regensburg | Germany | Associatedpartner |
| Achucarro Basque Center for Neuroscience Fundazioa | Leioa | Spain | Participant |
| Agencia Estatal Consejo Superior De Investigaciones Cientificas | Madrid | Spain | Participant |
| Universidad Complutense De Madrid | Madrid | Spain | Associatedpartner |
| Universidad Del Pais Vasco/ Euskal Herriko Unibertsitatea | Leioa | Spain | Associatedpartner |
| The Hebrew University of Jerusalem | Jerusalem | Israel | Participant |
| Aziende Chimiche Riunite Angelini Francesco - A.c.r.a.f. - SpA | Roma | Italy | Associatedpartner |
| Universita Degli Studi Di Catania | Catania | Italy | Participant |
| Thelial BV | Wageningen | Netherlands | Associatedpartner |
| Norges Teknisk-Naturvitenskapelige Universitet NTNU | Trondheim | Norway | Participant |
| Associação Accelbio | Cantanhede | Portugal | Associatedpartner |
| Faculdade De Medicina Da Universidade De Lisboa | Lisboa | Portugal | Participant |
| Humanized Solutions, Lda | Charneca Da Caparica | Portugal | Associatedpartner |
| Universidade Do Porto | Porto | Portugal | Associatedpartner |
| Bit Bio Limited | Girton | United Kingdom | Associatedpartner |
| John Wiley and Sons Ltd | Chichester | United Kingdom | Associatedpartner |
| King's College London | London | United Kingdom | Participant |
Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI